OPTOMICS - Combining optoacoustic imaging phenotypes and multi-omics to advance diabetes healthcare / Edukad projektid

programm [ H2020 ] partner-riik [ UK ] otsingusõna [ RAYFOS LTD ]

akronüüm:	OPTOMICS
algus:	2021-01-01
lõpp:	2025-12-31

programm:	H2020 - Horisont 2020
alaprogramm:	FET - Tulevased ja kujunemisjärgus tehnoloogiad
instrument:	RIA
projektikonkurss:	H2020-FETPROACT-2020-2
projekti number:	101017802
kestus kuudes:	60
partnerite arv:	6

lühikokkuvõte:	Diabetes has emerged as a global pandemic affecting more than 420 million people worldwide, a number expected to further rise in the next decades. The disease has very heterogeneous outcomes and accurate patient staging or prediction of subsets of individ

partneri jrk nr ja roll		partneri nimi	riik	kontaktisik	koduleht
1	koordinaator	TECHNISCHE UNIVERSITAET MUENCHEN	DE	Vasilis NTZIACHRISTOS	www.tum.de
2	partner	TARTU ULIKOOL	EE		www.ut.ee
3	partner	TATAA BIOCENTER AB	SE
4	partner	NIGHTINGALE HEALTH OY	FI
5	partner	RAYFOS LTD	UK		www.rayfos.com
6	partner	HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH	DE		www.helmholtz-muenchen.de